144 related articles for article (PubMed ID: 18566225)
1. STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' ends.
Lewis HD; Winter A; Murphy TF; Tripathi S; Pandey VN; Barton BE
Mol Cancer Ther; 2008 Jun; 7(6):1543-50. PubMed ID: 18566225
[TBL] [Abstract][Full Text] [Related]
2. Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines.
Barton BE; Murphy TF; Shu P; Huang HF; Meyenhofer M; Barton A
Mol Cancer Ther; 2004 Oct; 3(10):1183-91. PubMed ID: 15486184
[TBL] [Abstract][Full Text] [Related]
3. STAT3 Inhibition Induces Apoptosis in Cancer Cells Independent of STAT1 or STAT2.
Shodeinde A; Ginjupalli K; Lewis HD; Riaz S; Barton BE
J Mol Biochem; 2013 Feb; 2(1):18-26. PubMed ID: 25364701
[TBL] [Abstract][Full Text] [Related]
4. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.
Barton BE; Karras JG; Murphy TF; Barton A; Huang HF
Mol Cancer Ther; 2004 Jan; 3(1):11-20. PubMed ID: 14749471
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
[TBL] [Abstract][Full Text] [Related]
6. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.
Jing N; Li Y; Xiong W; Sha W; Jing L; Tweardy DJ
Cancer Res; 2004 Sep; 64(18):6603-9. PubMed ID: 15374974
[TBL] [Abstract][Full Text] [Related]
7. Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.
Gu J; Li G; Sun T; Su Y; Zhang X; Shen J; Tian Z; Zhang J
J Neurooncol; 2008 Aug; 89(1):9-17. PubMed ID: 18415045
[TBL] [Abstract][Full Text] [Related]
8. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
[TBL] [Abstract][Full Text] [Related]
9. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
[TBL] [Abstract][Full Text] [Related]
10. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
Gray MJ; Zhang J; Ellis LM; Semenza GL; Evans DB; Watowich SS; Gallick GE
Oncogene; 2005 Apr; 24(19):3110-20. PubMed ID: 15735682
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.
Gao B; Shen X; Kunos G; Meng Q; Goldberg ID; Rosen EM; Fan S
FEBS Lett; 2001 Jan; 488(3):179-84. PubMed ID: 11163768
[TBL] [Abstract][Full Text] [Related]
12. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
Huang C; Yang G; Jiang T; Zhu G; Li H; Qiu Z
Neoplasma; 2011; 58(5):396-405. PubMed ID: 21744993
[TBL] [Abstract][Full Text] [Related]
13. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
[TBL] [Abstract][Full Text] [Related]
14. MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.
Dai H; Wang C; Yu Z; He D; Yu K; Liu Y; Wang S
Cancer Biother Radiopharm; 2018 Apr; 33(3):103-109. PubMed ID: 29641255
[TBL] [Abstract][Full Text] [Related]
15. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
16. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
[TBL] [Abstract][Full Text] [Related]
17. Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.
Wu JC; Wang CT; Hung HC; Wu WJ; Wu DC; Chang MC; Sung PJ; Chou YW; Wen ZH; Tai MH
Prostate; 2016 Dec; 76(16):1469-1483. PubMed ID: 27416770
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and G2/M cell cycle arrest induced by a timosaponin A3 from Anemarrhena asphodeloides Bunge on AsPC-1 pancreatic cancer cells.
Kim Y; Kim KH; Lee IS; Park JY; Na YC; Chung WS; Jang HJ
Phytomedicine; 2019 Mar; 56():48-56. PubMed ID: 30668353
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
Chen T; Wang LH; Farrar WL
Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]